ArticleNeuro-oncology advances

Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomide.

Josephine A Mapunda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.